The impact of CXCL12 signaling on ovarian cancer progression depends on the delicate balance between its ability to summon and activate immune cells vs. its ability to cause pathological conditions in a tumor (Chen et al. 2018; Fucikova et al. 2021). Here, CXCL12 is linked to neoplasm.